REMAP-CAP Trial

All Done!

A bit more to do?    Log in


The latest from the Spiral blog . . .

Stew Duff, who makes what we do at Spiral technically possible

2021-02-23

He’s not a researcher signing up patients for life-saving clinical trials – but he does determine eligibility.

He’s not a doctor, or a nurse, seeing patients and delivering recovery results – but he does do patient follow-ups and reporting. 

He’s not on the front-lines, but he is helping to save lives from the back end.

 Meet Stew, one of our Developers »


  
 

Follow us on Twitter
     
 

Like us on Facebook



 

REMAP-CAP

REMAP-CAP is a Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia. The primary aim of the study is to identify the effect of a range of interventions to improve all-cause mortality at 90 days.

About the software

Spinnaker is a tailored, web based, software and database solution for managing your multi-centre clinical study including the recording of patient data, recording and alerting of events, inventory management and reporting on data collected during the course of your study. Spinnaker is user friendly, adaptable and can be delivered quickly. You can read more on the Spinnaker website or contact Audrey on spinnaker@spiral.co.nz.

 

You can get to know us a little better through our blog and social media pages accessed via the logout screen of this trial.

This instance of REMAP-CAP hosted on our RELENTLESS server